Clinical Trial Update: Astral VAPS AutoEPAP Clinical Trial [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Astral VAPS AutoEPAP for upper airway obstruction and respiratory insufficiency completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Failure
• Respiratory Insufficiency
• Upper Airway Obstruction

Drugs mentioned

• Astral VAPS AutoEPAP

Snippet

Sponsor: ResMed | Conditions: Upper Airway Obstruction, Respiratory Insufficiency | Phase 3 | Status: COMPLETED | Results posted: 2019-07-26